Australian Clinical Labs Limited (ASX:ACL)
Australia · Delayed Price · Currency is AUD 2.060
+0.020 (0.98%)
Jun 5, 2026, 4:10 PM AEST
Australian Clinical Labs Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, Australian Clinical Labs stock has a consensus rating of "Hold" and an average price target of $2.58. The average 1-year stock price forecast is 25.24% higher than the current stock price, while the lowest is $2.20 (+6.80%) and the highest is $3.50 (+69.90%).
Price Target: $2.58 (+25.24%)
Analyst Consensus: Hold
* Price targets were last updated on Mar 24, 2026.
Analyst Ratings
The average analyst rating for Australian Clinical Labs stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Oct '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 2 | 2 | 2 |
| Buy | 2 | 1 | 1 | 0 | 0 | 0 |
| Hold | 2 | 3 | 3 | 5 | 6 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 7 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ord Minnett | Ord Minnett | Hold Maintains $2.40 → $2.20 | Hold | Maintains | $2.40 → $2.20 | +6.80% | Mar 24, 2026 |
| Canaccord Genuity | Canaccord Genuity | Hold Downgrades $3.85 → $2.40 | Hold | Downgrades | $3.85 → $2.40 | +16.50% | Feb 17, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $2.80 → $2.40 | Hold | Maintains | $2.80 → $2.40 | +16.50% | Feb 17, 2026 |
Unknown Analyst Macquarie No rating | Macquarie | Hold Maintains $2.90 → $2.30 | Hold | Maintains | $2.90 → $2.30 | +11.65% | Feb 16, 2026 |
Financial Forecast
Revenue This Year
737.12M
from 741.27M
Decreased by -0.56%
Revenue Next Year
764.56M
from 737.12M
Increased by 3.72%
EPS This Year
0.16
from 0.18
Decreased by -7.45%
EPS Next Year
0.18
from 0.16
Increased by 10.91%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 740.5M | ||
| Avg | 737.1M | ||
| Low | 731.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.1% | ||
| Avg | -0.6% | ||
| Low | -1.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.18 | ||
| Avg | 0.16 | ||
| Low | 0.12 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.8% | ||
| Avg | -7.4% | ||
| Low | -34.4% |